OrganiGram Inc. (OGI)
1.53
-0.04 (-2.55%)
At close: Jan 14, 2025, 3:59 PM
1.56
2.22%
After-hours Jan 14, 2025, 07:44 PM EST
undefined% (undefined)
| Bid | 1.49 |
| Market Cap | 192.53M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.33 |
| PE Ratio (ttm) | -4.62 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 1.72 |
| Volume | 619,894 |
| Avg. Volume (20D) | 691,740 |
| Open | 1.57 |
| Previous Close | 1.57 |
| Day's Range | 1.50 - 1.59 |
| 52-Week Range | 1.31 - 2.91 |
| Beta | undefined |
About OGI
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also e...
Sector Healthcare
IPO Date May 21, 2019
Employees 914
Stock Exchange NASDAQ
Ticker Symbol OGI
Website https://www.organigram.ca
Analyst Forecast
According to 1 analyst ratings, the average rating for OGI stock is "Strong Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
OrganiGram Inc. is scheduled to release its earnings on Feb 11, 2025,
before market opens.
Analysts project revenue of $33.69M, reflecting a 25.78% YoY growth and earnings per share of -0.01, making a -90.91% decrease YoY.
Analysts project revenue of $33.69M, reflecting a 25.78% YoY growth and earnings per share of -0.01, making a -90.91% decrease YoY.
3 months ago ·
Source
+2.84%
Shares of cannabis stocks are trading higher follo...
Unlock content with
Pro Subscription
4 months ago ·
Source
-8.04%
Shares of cannabis stocks are trading lower after the DEA announced a delay on its final ruling on cannabis rescheduling until after the November presidential election.
